Case Western Reserve University Receives $1.5M Grant From Foundation Fighting Blindness to Test Possible New Treatment for Inherited Retinal Disease
July 09, 2024
July 09, 2024
CLEVELAND, Ohio, July 9 -- Case Western Reserve University issued the following news release:
There's only one U.S. Food and Drug Administration-approved therapy for an inherited retinal disease, and dozens of retinitis pigmentosa (RP) genes for which no therapy is available.
With a new three-year, $1.5 million grant from the Foundation Fighting Blindness, Shigemi Matsuyama, an associate professor of ophthalmology and visual sciences at the Case Western Reserve Universi . . .
There's only one U.S. Food and Drug Administration-approved therapy for an inherited retinal disease, and dozens of retinitis pigmentosa (RP) genes for which no therapy is available.
With a new three-year, $1.5 million grant from the Foundation Fighting Blindness, Shigemi Matsuyama, an associate professor of ophthalmology and visual sciences at the Case Western Reserve Universi . . .